论文部分内容阅读
目的:观察纳洛酮联合银杏达莫治疗急性脑梗死临床疗效。方法:将入选患者随机分为纳洛酮联合银杏达莫治疗组和银杏达莫对照组,于治疗前、治疗第5、10天分别进行C-反应蛋白、内皮素、血栓素,肝肾功能等血液相关指标检测及临床疗效观察。结果:治疗组相关指标明显下降,与对照组相比差异明显(P<0.05),且GCS评分较对照组明显升高。结论:纳洛酮联合银杏达莫治疗急性脑梗死临床疗效极佳。
Objective: To observe the clinical efficacy of naloxone combined with ginkgo biloba in the treatment of acute cerebral infarction. Methods: The selected patients were randomly divided into naloxone combined with ginkgo biloba and ginkgo biloba control group, before treatment, the treatment of C-reactive protein, endothelin, thromboxane, liver and kidney function Such as blood-related index detection and clinical efficacy observation. Results: The related indexes of the treatment group decreased significantly compared with the control group (P <0.05), and the GCS score was significantly higher than that of the control group. Conclusion: Naloxone combined with ginkgo biloba is effective in the treatment of acute cerebral infarction.